With winter on the way and people spending more time inside, the air they breathe becomes a more significant concern. This is especially true during cold and flu season.

Researchers at UBC Okanagan are examining a new air-cleaning device designed to capture airborne pathogens. Their goal is to provide a stronger way to reduce the spread of respiratory illnesses in enclosed settings.

Limitations of Current Ventilation Methods

According to study co-author Dr. Sunny Li, a professor in the School of Engineering, the standard method for reducing infectious disease transmission involves upgrading a building's ventilation system to manage airflow throughout large areas.

Some systems take things further by sending a stream of clean air directly toward an individual from a fixed location. This setup functions similarly to the air outlets found on passenger airplanes. However, Dr. Li notes several drawbacks. People must remain in the same position for the system to work effectively, or everyone in a shared space would need to use identical equipment at the same time. Constant airflow can also lead to dry eyes and skin, making long-term use uncomfortable.

"Ensuring high air quality while indoors is crucial for mitigating the transmission of airborne disease, particularly in shared environments," says Dr. Li. "Many Canadians spend nearly 90 percent of their time inside, making indoor air quality a critical factor for health and well-being."

Why Personalized Ventilation Matters

Postdoctoral researcher Dr. Mojtaba Zabihi, the study's first author, explains that room configurations and existing heating, ventilation and air conditioning systems can differ widely. These variations make it difficult to implement consistent airflow improvements, which reinforces the need for personalized ventilation options.

"We wanted to develop an innovative system that prevents occupants from inhaling contaminated air while allowing them to use a personalized ventilation system comfortably for extended periods," he says.

Working within UBC's Airborne Disease Transmission Research Cluster, the team introduced an induction-removal or jet-sink airflow approach. This method is designed to capture exhaled aerosols before they spread through the room.

A New Approach to Capturing Airborne Particles

Traditional personalized ventilation systems often rely on fast-moving air streams that may feel uncomfortable and become less effective when a person shifts position. The new design takes a different approach by guiding airflow around the user and continuously drawing contaminated particles into a localized purification area.

"Our design combines comfort with control," says Dr. Zabihi. "It creates a targeted airflow that traps and removes exhaled aerosols almost immediately -- before they have a chance to spread."

To test the system, researchers used computer simulations that modeled breathing, body heat and airflow during a 30-minute consultation scenario. They then compared its performance with standard personal ventilation systems.

Strong Reductions in Exposure Risk

The findings, recently published in Building and Environment, showed a striking difference. The new device lowered the chance of infection to 9.5 percent. By comparison, the risk was 47.6 percent with a typical personal setup, 38 percent with a personal ventilation system using an exhaust design, and 91 percent under regular room ventilation.

When positioned optimally, the device prevented inhalation of pathogens during the first 15 minutes of exposure. Only 10 particles out of 540,000 reached another person, and simulations indicated the system removed up to 94 percent of airborne pathogens.

"Traditional personalized ventilation systems can't adapt when people move or interact," explains study co-author Dr. Joshua Brinkerhoff. "It's a smart, responsive solution for spaces like clinics, classrooms or offices where close contact is unavoidable."

Future Potential for Safer Indoor Spaces

Dr. Brinkerhoff adds that the study illustrates how airflow engineering, not just filtration, can significantly enhance indoor air quality and safety. The next steps involve refining the system for use in larger rooms and testing physical prototypes in clinical and public environments.

As a member of Canada's National Model Codes Committee on Indoor Environment, Dr. Zabihi hopes this research will play a role in shaping future ventilation guidelines, ultimately helping create healthier and safer indoor spaces for everyone.

Read more …New airflow device captures indoor germs before they spread

Move over, colonoscopies -- researchers writing in ACS Sensors report that they have created tiny microspheres filled with bacteria that can sense the presence of blood, a key sign of gastrointestinal disease. These microspheres function like miniature "pills" that are swallowed and include magnetic particles so they can be easily collected from stool. After passing through mouse models with colitis, the sensors detected gastrointestinal bleeding within minutes. The team notes that the same bacterial system could eventually be engineered to identify other gut-related conditions.

"This technology provides a new paradigm for rapid and non-invasive detection of gastrointestinal diseases," says Ying Zhou, a co-author of the study.

Why Easier, Noninvasive Gut Diagnostics Are Needed

In the U.S., millions of people live with colorectal cancer or inflammatory bowel disease, including colitis, which can lead to intestinal bleeding, diarrhea and abdominal pain. Colonoscopy remains the gold-standard diagnostic tool. It relies on an endoscope, a camera-tipped flexible device that is carefully guided through the large intestine. Although it provides valuable medical insight, many individuals hesitate to undergo the procedure because it requires extensive preparation and can feel invasive. To develop an alternative, Zhou, Bang-Ce Ye, Zhen-Ping Zou and colleagues are exploring the use of bacteria that detect biomarkers such as heme, a component of red blood cells that signals bleeding inside the gut.

Building Bacterial Sensors That Survive Digestion

The team previously designed bacteria that emit light when they encounter heme, but the early versions broke down during digestion and were difficult to retrieve afterward. In the new study, the researchers protected the bacteria by enclosing them, along with magnetic particles, inside small droplets of sodium alginate, a thickening ingredient commonly found in foods. This produced sturdy hydrogel microspheres that travel through the digestive tract and can be removed from stool with a magnet. Initial laboratory tests confirmed that the hydrogel shield allowed the bacteria to survive simulated digestive conditions while still letting heme reach the sensor and trigger a glow.

Testing the Microspheres in Mouse Models of Colitis

The researchers then gave the microspheres orally to mice with varying levels of colitis, ranging from no disease activity to severe inflammation. After the spheres moved through the gastrointestinal tract, the team retrieved them using a magnet and reported three key findings:

  • Microsphere cleanup and signal analysis required about 25 minutes.
  • The sensors produced stronger light signals as disease severity increased, indicating higher levels of heme in animals with more advanced colitis.
  • Tests in healthy mice showed that the microspheres were biocompatible and safe.

Future Potential for Human Testing and Disease Monitoring

Although the technology has not yet been evaluated in humans, the researchers suggest that encapsulated bacterial sensors could one day help diagnose gastrointestinal diseases, monitor treatment responses and track changes in disease over time.

The authors acknowledge funding from the National Natural Science Foundation of China, the National Key Research and Development Program of China, and the China Postdoctoral Science Foundation.

Read more …This tiny pill could change how we diagnose gut health

Following the federal government’s changes to COVID-19 vaccine eligibility and recommendations in 2025, many people are wondering whether they can get COVID-19 vaccines for themselves or their children[1].

In May 2025, the U.S. Food and Drug Administration limited eligibility for updated COVID-19 vaccines[2] to people ages 65 years and up[3] and to those under 65 with a “high-risk” condition. In September, the Centers for...

Read more

More Articles …